Pan Asia Chemical Corp. AI Stock Analysis
Pan Asia Chemical Corp. (4707) AI Stock Analysis
Pan Asia Chemical Corp.
(TPEx:4707)
The score is primarily constrained by weak operating performance and negative technical momentum. Balance-sheet strength and improved cash flow provide support, but the moderate valuation and limited dividend yield do not sufficiently offset the fundamental risks.
Pan Asia Chemical Corp. (4707) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 11.86B
- Dividend Yield
- 0.92%
- Average Volume (3M)
- 3.17M
- Price to Earnings (P/E)
- 21.4
- Beta (1Y)
- 0.79
- Revenue Growth
- -9.16%
- EPS Growth
- 67.21%
- Country
- TW
- Employees
- 109
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Pan Asia Chemical Corp. Business Overview & Revenue Model
Company Description
Pan Asia Chemical Co. (PACC), a Taiwanese firm, specializes in the manufacturing, sale, and distribution of diverse chemical compounds within Taiwan and internationally. Its extensive product portfolio features a wide array of surfactants, including...
Pan Asia Chemical Corp. Financial Statement Overview
Summary
Mixed financial performance: a solid balance sheet and improved cash flow are offset by declining revenue, negative gross and operating profitability, and weak underlying earnings quality.
Income Statement
35NegativeBalance Sheet
78PositiveCash Flow
55Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.29B | 1.34B | 1.44B | 1.32B | 1.83B | 1.73B |
| Gross Profit | 20.81M | -32.77M | 19.40M | 91.63M | 268.11M | 193.59M |
| EBITDA | 159.44M | -54.60M | 38.30M | 461.40M | 545.34M | 438.98M |
| Net Income | 520.75M | 360.26M | 381.79M | 347.28M | 402.10M | 342.98M |
Balance Sheet | ||||||
| Total Assets | 10.89B | 8.68B | 8.69B | 8.41B | 8.48B | 8.79B |
| Cash, Cash Equivalents and Short-Term Investments | 574.25M | 571.16M | 591.65M | 505.14M | 564.25M | 592.69M |
| Total Debt | 2.22B | 2.24B | 2.38B | 2.06B | 2.36B | 2.63B |
| Total Liabilities | 2.62B | 2.47B | 2.66B | 2.40B | 2.80B | 2.96B |
| Stockholders Equity | 8.27B | 6.21B | 6.03B | 6.01B | 5.68B | 5.83B |
Cash Flow | ||||||
| Free Cash Flow | 152.02M | 73.17M | 38.18M | 25.90M | 398.21M | 146.66M |
| Operating Cash Flow | 161.56M | 86.36M | 40.78M | 36.91M | 406.18M | 158.64M |
| Investing Cash Flow | 124.45M | 94.87M | -175.77M | 264.07M | -58.78M | -105.92M |
| Financing Cash Flow | -230.32M | -226.05M | 203.97M | -366.34M | -320.91M | -169.06M |
Pan Asia Chemical Corp. Peers Comparison
Overall Rating
TW:650969Neutral
TW:170865Neutral
TW:475558Neutral
TW:470754Neutral
TW:130446Neutral
TW:172739Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 69Neutral | TWD 9.02B | 12.96 | ― | 3.23% | 2.00% | 57.23% | |
| 65Neutral | TWD 11.22B | 11.02 | ― | 3.52% | 3.55% | 34.35% | |
| 58Neutral | TWD 12.34B | 27.45 | ― | 3.05% | -11.09% | 37.46% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 54Neutral | TWD 11.15B | 21.39 | ― | 0.92% | -9.16% | 67.21% | |
| 46Neutral | TWD 12.12B | -6.20 | ― | 1.32% | -9.36% | 30.01% | |
| 39Underperform | TWD 11.75B | 121.53 | ― | 0.18% | 20.16% | 962.24% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:4707 | Pan Asia Chemical Corp. | 27.30 | 17.83 | 188.22% | |
| TW:1304 | USI Corporation | 11.40 | 0.23 | 2.03% | |
| TW:1708 | Sesoda Corporation | 45.40 | 14.25 | 45.76% | |
| TW:1727 | Chung Hwa Chemical Industrial Works Ltd. | 84.10 | 47.31 | 128.60% | |
| TW:4755 | San Fu Chemical Co., Ltd. | 121.50 | 16.85 | 16.10% | |
| TW:6509 | Taiwan Hopax Chemicals Manufacturing Co. Ltd. | 43.20 | 11.04 | 34.33% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
